KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Raw Materials (2017 - 2025)

LifeMD's Raw Materials history spans 8 years, with the latest figure at $854980.0 for Q4 2025.

  • For Q4 2025, Raw Materials fell 43.23% year-over-year to $854980.0; the TTM value through Dec 2025 reached $854980.0, down 43.23%, while the annual FY2025 figure was $854980.0, 43.23% down from the prior year.
  • Raw Materials reached $854980.0 in Q4 2025 per LFMD's latest filing, down from $931352.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.5 million in Q4 2024 to a low of $74056.0 in Q3 2021.
  • Average Raw Materials over 5 years is $888752.6, with a median of $931352.0 recorded in 2025.
  • Peak YoY movement for Raw Materials: plummeted 69.89% in 2021, then surged 1468.14% in 2022.
  • A 5-year view of Raw Materials shows it stood at $81427.0 in 2021, then soared by 1468.14% to $1.3 million in 2022, then decreased by 4.7% to $1.2 million in 2023, then increased by 23.77% to $1.5 million in 2024, then plummeted by 43.23% to $854980.0 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Raw Materials are $854980.0 (Q4 2025), $931352.0 (Q3 2025), and $876944.0 (Q2 2025).